Trans-ACBD

CAS No. 117488-23-0

Trans-ACBD( trans-1-Aminocyclobutane-1,3-dicarboxylic acid | trans ABCD )

Catalog No. M17168 CAS No. 117488-23-0

1-Aminocyclobutane-1, 3-dicarboxylic acid is an effective and specific N-methyl-D-aspartate receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 In Stock
5MG 62 In Stock
10MG 93 In Stock
25MG 219 In Stock
50MG 372 In Stock
100MG 553 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Trans-ACBD
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Aminocyclobutane-1, 3-dicarboxylic acid is an effective and specific N-methyl-D-aspartate receptor agonist.
  • Description
    Trans-ABCD is a potent and selective NMDA agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    trans-1-Aminocyclobutane-1,3-dicarboxylic acid | trans ABCD
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    aspartate
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    117488-23-0
  • Formula Weight
    159.14
  • Molecular Formula
    C6H9NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1[C@@H](C[C@@]1(C(=O)O)N)C(=O)O
  • Chemical Name
    (1r,3r)-1-Aminocyclobutane-1,3-dicarboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Thomas HL, et al. cis-2,4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist. 1990, 182(3):397-404
molnova catalog
related products
  • AalphaC

    AalphaC is a potential carcinogen.

  • SHMT-IN-2

    SHMT-IN-2 (compound 2) is a specific human SHMT1/2 small molecule inhibitor that acts on SHMT1 (IC50: 13 nM) and SHMT2 (IC50: 66 nM). SHMT-IN-2 inhibits the growth of many human cancer cells and is sensitive to B-cell lymphoma.

  • Opigolix

    Opigolix, a Gonadotropin-releasing hormone receptor antagonist, treats hormone-dependent conditions by inhibiting the actions of gonadotropin-releasing hormone (GnRH).